The Prevalence and Risk Factors of Cardiovascular Comorbidity in Patients with Severe and Very Severe COPD
Keywords:
severe COPD, very severe COPD, risk factors, cardiovascular comorbidity
Abstract
Cardiovascular comorbidities are most frequent comorbidities in COPD and are responsible for many deaths in those patients. The aim of the study was to investigate the prevalence and the risk factors of these comorbidities. In the survey 114COPD patients were included with severe and very severe stage of the disease, FEV1
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
D. Mannino (2002) COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. 121(5), 121-126.
S. Sidney (2005) COPD and Incident Cardiovascular Disease Hospitalizations and Mortality: Kaiser Permanente Medical Care Program. 128(4). https://doi.org/10.1378/chest.128.4.2068
I. Andriana (2015) Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?. 46, 846-849.
C. Arnaud (2013) Comorbidities of COPD. 22, 454-475.
E. Dionne (2015) Impact of cardiovascular comorbidities on COPD Assessment Test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the Chance study. 5(7), e007536. https://doi.org/10.1136/bmjopen-2014-007536
J. Izquierdo (2010) Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.Int J Chron Obstruct Pulmon Dis. 8(5), 387-394.
F. Michael (2012) Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). 679-686. https://doi.org/10.2147/COPD.S36222
W. VanDijk (2010) Interaction in COPD experiment (ICE): A hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease. 74(2), 277-280. https://doi.org/10.1016/j.mehy.2009.09.012
Don Sin, S. Man (2005) Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. 83(1), 8-13. https://doi.org/10.1139/y04-116
Sin, S. D.D. Man (2008) Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease. 14(2), 115-121. https://doi.org/10.1097/mcp.0b013e3282f45ffb
Martinez, C. Miguel, D. D.J.Mannino (2014) Defining COPD-related comorbidities. 1(1), 51-63. https://doi.org/10.15326/jcopdf.1.1.2014.0119
Peter Barnes (2010) Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs. 7(3), e1000220. https://doi.org/10.1371/journal.pmed.1000220
Don Sin, S. Man (2005) Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality. 2(1), 8-11. https://doi.org/10.1513/pats.200404-032ms
D. Mannino (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. 32(4), 962-969. https://doi.org/10.1183/09031936.00012408
R. Langen (2013) Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. 45(10), 2245-2256. https://doi.org/10.1016/j.biocel.2013.06.015
M. Donahoe (1989) Oxygen Consumption of the Respiratory Muscles in Normal and in Malnourished Patients with Chronic Obstructive Pulmonary Disease. 140(2), 385-391. https://doi.org/10.1164/ajrccm/140.2.385
M. Li Wei (2004) Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease. 141(10), 764-770. https://doi.org/10.7326/0003-4819-141-10-200411160-0000721
T. Perez (2015) Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. 10, 1663-1672. https://doi.org/10.2147/COPD.S8240822
H. Müllerová (2014) Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care. 9(1), 85540. https://doi.org/10.1371/journal.pone.008554
H. Van Remoortel1 (2014) Risk Factors and Comorbidities in the Preclinical Stages of Chronic Obstructive Pulmonary Disease. 189(1), 30-38. https://doi.org/10.1164/rccm.201307-1240oc
W. Chen (2015) Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. 9, 213-2600. https://doi.org/10.1016/s2213-2600(15)00241-6
L. Roever, E. Resende (2015) Cardiovascular Comorbidities in COPD Patients.
P. Jones (2013) Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. 42(3), 647-654. https://doi.org/10.1183/09031936.00125612
M. Masaki (2014) Analysis of comorbid factors that increase the COPD assessment test scores Respir. (1), 13. https://doi.org/10.1186/1465-9921-15-13
S. Leea (2014) The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. 108(4), 600-608. https://doi.org/10.1016/j.rmed.2013.12.014
P. Jones (2009) Development and first validation of the COPD Assessment Test. 34(3), 648-654. https://doi.org/10.1183/09031936.00102509
N. Sarioglua (2016) Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD?. 22(1), 11-17. https://doi.org/10.1016/j.rppnen.2015.08.007
M. MacDonald (2016) Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. 4(2), 138-148. https://doi.org/10.1016/s2213-2600(15)00509-3
C. Terzano (2010) Comorbidity, Hospitalization, and Mortality in COPD: Results from a Longitudinal Study. 188(4), 321-329. https://doi.org/10.1007/s00408-009-9222-y
S. Man (2006) C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. 61(10), 849-853. https://doi.org/10.1136/thx.2006.059808
S. Patil (2003) In-Hospital Mortality Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease. 163(10), 1180. https://doi.org/10.1001/archinte.163.10.1180
A. Wong (2008) Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Influence of Social Factors in Determining Length of Hospital Stay and Readmission Rates. 15(7), 361-364. https://doi.org/10.1155/2008/569496
R. Kessler (1999) Predictive Factors of Hospitalization for Acute Exacerbation in a Series of 64 Patients with Chronic Obstructive Pulmonary Disease. 159(1), 158-164. https://doi.org/10.1164/ajrccm.159.1.9803117
Published
2016-05-09
Issue
Section
License
Copyright (c) 2016 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.